the available information indicates that cinacalcet should continue to be avoided in patients with stage 3–4 CKD. The undesirable decrease in serum calcium and increase in serum phosphorus ...

They found no significant differences in serum phosphate, calcium ... These investigators compared 92 patients with stable CKD who were undergoing chronic hemodialysis with 182 age- and sex ...

Engaging patients in discussions about different phosphate binders and their unique characteristics is key to improving adherence and satisfaction. New therapies that reduce pill size or burden while ...

Cite this: Evaluation and Management of Nephrolithiasis in the Aging Population With Chronic Kidney Disease - Medscape ... older patient in one trial was calcium oxalate (74%), uric acid ...